ISLB 2026 will bring together international experts in the field of Liquid Biopsy to share latest advances in the clinical field. Clinical best practices related to liquid biopsy will be presented, new consensus will be reached, and the latest advancements on cellular and molecular diagnostic technologies will be discussed. This meeting is an excellent opportunity to interact with world experts in the field of Liquid Biopsy. Attending will be an international community of healthcare professional involved in cancer patient management, scientists, research and development staff, account and business development managers, laboratory leaders, and product specialists in liquid biopsy.